Trulicity (dulaglutide) - Eli Lilly
Zepbound (tirzepatide) - Eli Lilly
METSAFE: Metabolic Surgery for Atrial Fibrillation Elimination (clinicaltrials.gov) - Nov 27, 2025 - P4 | N=100 | Not yet recruiting | Sponsor: Ali Aminian | Trial completion date: Mar 2029 ➔ Mar 2030 | Initiation date: Aug 2025 ➔ Feb 2026 | Trial primary completion date: Dec 2028 ➔ Dec 2029 
Trial completion date • Trial initiation date • Trial primary completion date Cardiovascular • Genetic Disorders • Obesity
http://clinicaltrials.gov/ct2/show/NCT07027969
 
Nov 27, 2025